Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients

NCT02770807 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Nervous System Disease
Genetic Syndrome

Interventions

DRUG: EryDex Low dose DSP
DRUG: EryDex High dose DSP
DRUG: Pooled Placebo

Sponsor

Quince Therapeutics S.p.A.